epigallocatechin gallate has been researched along with Chromosomal Triplication in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benejam, B; Bizot, JC; Blehaut, H; Catuara, S; Covas, MI; Cuenca, A; De la Torre, R; de Lagran, MM; De Sola, S; Delabar, JM; Dierssen, M; Duchon, A; Farré, M; Fitó, M; Herault, Y; Janel, N; Langohr, K; Pons, M; Pujadas, M; Rodriguez, J | 1 |
de Bari, L; De Rasmo, D; Granese, B; Papa, S; Rossi, L; Scala, I; Signorile, A; Vacca, RA; Valenti, D | 1 |
1 trial(s) available for epigallocatechin gallate and Chromosomal Triplication
Article | Year |
---|---|
Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans.
Topics: Adolescent; Adult; Animals; Biomarkers; Catechin; Chromosomes, Human, Pair 16; Cognition; Disease Models, Animal; Double-Blind Method; Down Syndrome; Dyrk Kinases; Female; Gene Expression Regulation; Hippocampus; Humans; Male; Mice; Mice, Transgenic; Mosaicism; Phosphorylation; Pilot Projects; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Trisomy; Young Adult | 2014 |
1 other study(ies) available for epigallocatechin gallate and Chromosomal Triplication
Article | Year |
---|---|
Epigallocatechin-3-gallate prevents oxidative phosphorylation deficit and promotes mitochondrial biogenesis in human cells from subjects with Down's syndrome.
Topics: Adenosine Triphosphate; Catechin; Cells, Cultured; Chromosomes, Human, Pair 21; Down Syndrome; Fibroblasts; Heat-Shock Proteins; Humans; Mitochondria; Oxidative Phosphorylation; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Reactive Oxygen Species; Signal Transduction; Sirtuin 1; Tea; Transcription Factors; Trisomy | 2013 |